https://xl-protein.com/wordpress/wp-content/uploads/2021/02/XLplogo3.png00XL-proteinhttps://xl-protein.com/wordpress/wp-content/uploads/2021/02/XLplogo3.pngXL-protein2025-06-10 11:00:002025-06-10 11:20:12XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology
NEW YORK and LONDON, Feb. 15, 2023 (GLOBE NEWSWIRE) — Akari…
https://xl-protein.com/wordpress/wp-content/uploads/2021/02/XLplogo3.png00XL-proteinhttps://xl-protein.com/wordpress/wp-content/uploads/2021/02/XLplogo3.pngXL-protein2023-02-15 10:04:522023-02-21 10:07:28Akari Therapeutics Announces Pre-Clinical Development Progress Toward Potential IND on Long-Acting PAS-Nomacopan for Geographic Atrophy (GA)
